文献速递妇科

黑人患者子宫内膜癌肿瘤的分子谱

Molecular profiles of endometrial cancer tumors among Black patients.
PubMed 文献 · Gynecol Oncol · 2022-04-28

该研究从6家机构收集248例子宫内膜癌样本及自报种族数据,由Caris Life Sciences进行肿瘤分子谱分析。黑人患者105例(42%),白人患者143例(58%)。黑人患者中浆液性癌(58% vs 36%)和癌肉瘤(25% vs 16%)更常见,子宫内膜样癌较少见(17% vs 48%)(p < 0.01)。按组织学分层后,黑人与白人患者肿瘤间无显著差异。

要点

  • 黑人患者浆液性癌和癌肉瘤比例更高,子宫内膜样癌比例更低(p < 0.01)。
  • 基因突变差异与种族间组织学差异相对应,TP53突变在浆液性肿瘤中占主导。
  • 按组织学分层后,黑人与白人患者肿瘤间无显著差异。

核心结论

  • 该队列中黑人女性肿瘤占比较高,独特的分子谱主要由黑人女性中更具侵袭性的组织学亚型驱动。

研究设计与样本

  • 从6家机构收集248例子宫内膜癌样本及自报种族数据,由Caris Life Sciences进行综合肿瘤分子谱分析。

主要发现

  • 黑人患者105例(42%),白人患者143例(58%)。
  • 黑人患者中浆液性癌占58%、白人患者占36%;癌肉瘤黑人患者占25%、白人患者占16%;子宫内膜样癌黑人患者占17%、白人患者占48%(p < 0.01)。
  • TP53突变在浆液性肿瘤中占主导;子宫内膜样肿瘤中ARID1A突变最常见,并观察到高比例的MSI-H、MMRd和TMB-H。
  • 癌肉瘤中黑人患者激素受体表达较高(PR 23.4%,ER 30.8%)。
  • 按组织学分层后,黑人与白人女性肿瘤间无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Disparate outcomes exist between Black and White patients with endometrial cancer (EC). One contributing factor is the disproportionately low representation of Black patients in clinical trials and in tumor molecular profiling studies. Our objective was to investigate molecular profiles of ECs in a cohort with a high proportion of tumors from Black patients. METHODS: A total of 248 EC samples and self-reported race data were collected from 6 institutions. Comprehensive tumor profiling and analyses were performed by Caris Life Sciences. RESULTS: Tumors from 105 (42%) Black and 143 (58%) White patients were included. Serous histology (58% vs 36%) and carcinosarcoma (25% vs 16%), was more common among Black patients, and endometrioid was less common (17% vs 48%) (p < 0.01). Differences in gene mutations between cohorts corresponded to observed histologic differences between races. Specifically, TP53 mutations were predominant in serous tumors. In endometrioid tumors, mutations in ARID1A were the most common, and high rates of MSI-H, MMRd, and TMB-H were observed. In carcinosarcoma tumors, hormone receptor expression was high in tumors of Black patients (PR 23.4%, ER 30.8%). When stratified by histology, there were no significant differences between tumors from Black and White women. CONCLUSIONS: This cohort had a high proportion of tumors from Black women. Distinct molecular profiles were driven primarily by more aggressive histologic subtypes among Black women. Continued effort is needed to include Black women and other populations under-represented in EC molecular profiling studies as targeted therapies and personalized medicine become mainstream.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Wilhite AM, Baca Y, Xiu J, et al. Molecular profiles of endometrial cancer tumors among Black patients. Gynecol Oncol. 2022. PMID: 35490034. doi:10.1016/j.ygyno.2022.04.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。